In type 2 diabetes, dipeptidyl peptidase-4 inhibitors do not increase pancreatitis

被引：1
|
作者：
Morey-Vargas, Oscar L. [1 ]
Montori, Victor M. [1 ]
机构：
[1] Mayo Clin, Rochester, MN 55905 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2014年 / 160卷 / 02期
关键词：
THERAPIES;
D O I：
10.7326/0003-4819-160-2-201401210-02008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Dipeptidyl Peptidase-4 Inhibitors Do Not Increase the Risk of Cardiovascular Events in Type 2 Diabetes
    Kim, Seoyoung C.
    Glynn, Robert
    Liu, Jun
    Everett, Brendan
    Goldfine, Allison
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 188 - 189
  • [2] Review: Dipeptidyl peptidase-4 inhibitors do not increase overall adverse events in type 2 diabetes
    Chatterjee, Saurav
    Chatterjee, Sanjay
    ANNALS OF INTERNAL MEDICINE, 2013, 158 (08)
  • [3] Do Dipeptidyl Peptidase-4 Inhibitors Increase the Risk of Heart Failure in Patients with Type 2 Diabetes?
    Hassanabad, Mortaza Fatehi
    Hassanabad, Ali Fatehi
    Fatehi, Mohammad
    CURRENT DIABETES REVIEWS, 2022, 18 (08)
  • [4] Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study
    Seoyoung C. Kim
    Robert J. Glynn
    Jun Liu
    Brendan M. Everett
    Allison B. Goldfine
    Acta Diabetologica, 2014, 51 : 1015 - 1023
  • [5] Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study
    Kim, Seoyoung C.
    Glynn, Robert J.
    Liu, Jun
    Everett, Brendan M.
    Goldfine, Allison B.
    ACTA DIABETOLOGICA, 2014, 51 (06) : 1015 - 1023
  • [6] Acute pancreatitis in patients with type 2 diabetes mellitus treated with dipeptidyl peptidase-4 inhibitors
    Yang, Tzu-Lin
    Shen, Mei-Chiou
    Yu, Ming-Lung
    Huang, Yaw-Bin
    Chen, Chung-Yu
    JOURNAL OF FOOD AND DRUG ANALYSIS, 2016, 24 (02) : 450 - 454
  • [7] Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes
    Jinsong Geng
    Hao Yu
    Yiwei Mao
    Peng Zhang
    Yingyao Chen
    PharmacoEconomics, 2015, 33 : 581 - 597
  • [8] Dipeptidyl peptidase-4 inhibitors: their role in the management of type 2 diabetes
    Mkele, Gail
    JOURNAL OF ENDOCRINOLOGY METABOLISM AND DIABETES OF SOUTH AFRICA, 2015, 20 (01) : 64 - 66
  • [9] Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes
    Scheen, Andre J.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (04) : 505 - 524
  • [10] Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes
    Geng, Jinsong
    Yu, Hao
    Mao, Yiwei
    Zhang, Peng
    Chen, Yingyao
    PHARMACOECONOMICS, 2015, 33 (06) : 581 - 597
12345